Appropriate Antiemetic Therapy for High- and Moderate Emetic Risk Antineoplastic Agents - ICD-10-CM Quality Payment Program Measure

Quality Measure Description High Priority Submission Methods
Appropriate Antiemetic Therapy for High- and Moderate Emetic Risk Antineoplastic AgentsPercentage of cancer patients aged 18 years and older treated with high- or moderate-emetic risk antineoplastic agents who are administered appropriate pre-treatment antiemetic therapyNORegistry

Linked ICD-10 Codes

The following ICD-10-CM codes are linked to the quality measure appropriate antiemetic therapy for high- and moderate emetic risk antineoplastic agents when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).

ICD CodeDescriptionCategory

View All Quality Payment Program Measures